Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02JKY
|
|||
Former ID |
DNCL003080
|
|||
Drug Name |
TD-9855
|
|||
Indication | Pain [ICD-11: MG30-MG3Z] | Phase 2 | [1] | |
Orthostatic hypotension [ICD-11: BA21; ICD-10: I95.1; ICD-9: 458] | Phase 1 | [2] | ||
Structure |
Download2D MOL |
|||
Formula |
C18H18F3NO
|
|||
Canonical SMILES |
C1CNCCC1C2=CC=CC=C2COC3=C(C=C(C=C3F)F)F
|
|||
InChI |
1S/C18H18F3NO/c19-14-9-16(20)18(17(21)10-14)23-11-13-3-1-2-4-15(13)12-5-7-22-8-6-12/h1-4,9-10,12,22H,5-8,11H2
|
|||
InChIKey |
TZIALEBTHQWNAO-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1227056-84-9
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Norepinephrine transporter (NET) | Target Info | Modulator | [1] |
Serotonin transporter (SERT) | Target Info | Modulator | [1] | |
KEGG Pathway | Serotonergic synapse | |||
NetPath Pathway | TCR Signaling Pathway | |||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
5HT1 type receptor mediated signaling pathway | ||||
5HT2 type receptor mediated signaling pathway | ||||
5HT3 type receptor mediated signaling pathway | ||||
5HT4 type receptor mediated signaling pathway | ||||
Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
WikiPathways | Monoamine Transport | |||
NRF2 pathway | ||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
SIDS Susceptibility Pathways | ||||
Synaptic Vesicle Pathway | ||||
Serotonin Transporter Activity |
References | Top | |||
---|---|---|---|---|
REF 1 | Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor. Int J Neuropsychopharmacol. 2014 Dec 13;18(2). pii: pyu027. | |||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.